Incentives and Long-Acting Injectable Adherence After Involuntary Hospitalization

ENROLLING BY INVITATION

NCT07130500

NA

Sponsor: Stanford University

Summary

This study is a randomized controlled trial evaluating the impact of financial incentives on medication adherence among individuals with schizophrenia, schizoaffective disorder, or bipolar disorder and/or co-occurring substance use disorder who are recently discharged from involuntary hospitalization or are at high risk of future involuntary hospitalization. Participants will be randomized to receive financial incentives for adherence to long-acting injectable medications or to a control group.

Official title: Can Financial Incentives Improve Medication Adherence and Patient Outcomes After Involuntary Hospitalization?

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

1000

Start Date

2026-03-09

Completion Date

2030-03

Last Updated

2026-03-27

Healthy Volunteers

No

Conditions

Schizophrenia Disorder Schizoaffective Disorder Bipolar Disorder (BD)Substance Use Disorder (SUD)

Interventions

BEHAVIORAL

Financial incentives for adherence to long-acting injectable medication

This intervention is a randomized controlled trial where patients in the treatment group are offered financial incentives for taking long-acting injectable (LAI) versions of the antipsychotic and substance use disorder medications they need and the control group receives the status quo standard of care.

BEHAVIORAL

Standard of care with monthly surveys

Receives standard outpatient care and incentives for completing monthly surveys.